Home › Bristol-Myers' gets early approval of combo cancer treatment
 

Keywords :   


Bristol-Myers' gets early approval of combo cancer treatment

2015-10-01 20:40:07| Biotech - Topix.net

The first combination of breakthrough drugs that boost the immune system to fight cancer has been approved, giving maker Bristol-Myers Squibb an early lead over competitors testing their own combos in a pharmaceutical gold rush of sorts. The Food and Drug Administration has given accelerated approval to a regimen combining the New York-based drugmaker's two immuno-oncology drugs, Opdivo and Yervoy, to treat patients with advanced melanoma who have a particular genetic variation.

Tags: early treatment approval cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Hurricane Beryl Graphics
03.07Farm Progress America, July 3, 2024
03.07Farm Progress America, July 3, 2024
03.07Hurricane Beryl Forecast Discussion Number 19
03.07Hurricane Beryl Wind Speed Probabilities Number 19
03.07Hurricane Beryl Public Advisory Number 19
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Hurricane Beryl Forecast Advisory Number 19
More »